Bilateral Palatal Synechiae With Cleft Palate: A Rare Entity.

Cleft Palate Craniofac JNov 21, 2025 (epub)
Case ReportPlastic SurgeryPediatricsOtolaryngology (ENT)

Amit Agarwal, Pritika Srivastava

✦ AI-curated · Sources linked

Case in brief

A 15-day-old male infant was brought for assessment of feeding difficulties. Examination showed a cleft palate with bilateral lateral intraoral synechiae, extending from the palate’s free borders toward the floor of the mouth. The report identifies this combination as lateral synechiae syndrome. The abstract does not describe the infant’s treatment or subsequent outcome.

What made this case unusual

The notable finding was bilateral lateral intraoral adhesions occurring with a cleft palate in a neonate presenting with feeding difficulty.

Diagnostic / clinical pearl

In an infant with cleft palate and feeding difficulty, examine for lateral intraoral adhesions, which may contribute to functional impairment.

Source

PubMed · PMID 41269888

Published in Cleft Palate Craniofac J. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Plastic Surgery

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.